Also trades as: AVCR.V (TSXV) · $vol 0M
AVCRF OTC
Avricore Health Inc.
1W: +0.0%
1M: -96.8%
3M: -97.7%
YTD: -97.5%
1Y: -98.3%
3Y: -99.6%
5Y: -99.5%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$1M
+52.1% ▲
Capital Expenditures
$205K
+80.4% ▲
Free Cash Flow
$799K
+306.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$856K
+348.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$2M | -$818K | -$701K | -$669K |
| Depreciation & Amort. | $0 | $18K | $183K | $420K | $450K |
| Stock-Based Comp. | $130K | $496K | $332K | $704K | $541K |
| Change in Working Capital | -$471K | -$78K | -$143K | $233K | -$112K |
| Other Non-Cash Items | $291K | $38K | $9K | $5K | $794K |
| Operating Cash Flow | -$1M | -$1M | -$438K | $660K | $1M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$140K | -$1M | -$1M | -$181K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | -$10K | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$35K | -$10K | -$25K | -$24K |
| Investing Cash Flow | $0 | -$140K | -$1M | -$1M | -$205K |
| — Financing Activities — | |||||
| Net Debt Issuance | $926K | $0 | $0 | $0 | -$30K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$40K | $681K | $254K | $42K | $87K |
| Financing Cash Flow | $2M | $3M | $254K | $42K | $57K |
| Net Change in Cash | $289K | $2M | -$1M | -$344K | $856K |
| Cash End of Period | $303K | $2M | $621K | $277K | $1M |
| Free Cash Flow | -$1M | -$1M | -$2M | -$386K | $799K |